This research will be conducted nationwide in patients with autoimmune gastritis, focusing on their clinical characteristics, possible risk factors, and multi-omics analysis. Changes in gastrointestinal microbiota, host and microbial metabolism, gene transcription and biomarkers of autoimmune gastritis will be explored to provide evidence for further precise therapy of the disease.
Autoimmune gastritis is a chronic progressive disease that may develop into gastric cancer. However, on account of its low morbidity, atypical clinical and endoscopic manifestation, demanding technique for detection of serological markers, the diagnosis and treatment of this disease remains challenging. Therefore, there's inadequate studies focusing on its pathogenesis, metabolism, gene transcription, microbiota etc. In recent years, multi-omics analysis provides clinicians with depth and breadth understandings of diseases. This research, as well, aims at enhancing clinicians' knowledge of autoimmune gastritis to reduce the occurrence of neuroendocrine tumors, gastric cancer, pernicious anemia and other complications.
Study Type
OBSERVATIONAL
Enrollment
450
Fecal genome, serum metabolome, leukocyte transcriptome, gastric mucosa genome
Shanghai Institute of Digestive Disease
Shanghai, Shanghai Municipality, China
RECRUITINGDifferences in microbiome
Differences in microbiome within or between groups will be explored by metagenomic sequencing and validated by molecular biology experiments
Time frame: 1 year
Differences in metabolome
Differences in microbiome within or between groups will be explored by mass spectrometry and validated by molecular biology experiments
Time frame: 1 year
Differences in transcriptome
Differences in microbiome within or between groups will be explored by transciptome sequencing and validated by molecular biology experiments
Time frame: 1 year
Differences in genome
Differences in microbiome within or between groups will be explored by 16s RNA sequencing and validated by molecular biology experiments
Time frame: 1 year
Differences in clinical outcomes
Differences in clinical outcomes of Group 1, whether subjects have complications, such as folic acid or vitamin B12 deficiency (folic acid\<3.1ug/L, vitamin B12\<180pg/ml), anemia ( male Hb\<130g/L, female Hb\<115g/L), hyperplastic polyp, pseudopolyp, pyloric adenoma, type 1 neuroendocrine tumor or gastric cancer (pathologically confirmed), all these complications will be reported separately
Time frame: 1 year
Differences in lifestyle
Differences in lifestyle within or between groups acquired by food frequency questionnaire and analyzed by statistical approaches
Time frame: 1 year
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.